 DUBLIN, Ireland and TREVOSE, Pa., July 29, 2021 GLOBE NEWSWIRE -- Strongbridge Biopharma plc, Nasdaq: SBBP Strongbridge, a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs, today announced in accordance with Rule 2.10 of the Irish Takeover Rules that, as of the close of business on July 28, 2021, Strongbridges issued share capital, excluding treasury shares, is comprised of 67,828,952 ordinary shares with a par value of 0.01 per share. Strongbridges ordinary shares are traded on the Nasdaq under the symbol SBBP. The International Securities Identification Number ISIN of the Strongbridge ordinary shares is IE00BYZ5XL97. 